Tiemonium Methylsulphate

This article discusses the use of Tiemonium Methylsulphate, in combination with Colchicine, in clinical trials for the treatment of calcium pyrophosphate deposition disease (CPPD). The study aims to evaluate the effectiveness of this drug combination in managing inflammation and symptoms associated with CPPD, a condition that affects joints and can cause arthritis-like symptoms.

Related diseases and areas:

• Nephropathy
• Arteriosclerosis
• Acute myocardial infarction
• Chondrocalcinosis

TIFCEMALIMAB

Tifcemalimab is an investigational immunotherapy drug being studied in clinical trials for small cell lung cancer (SCLC). Current trials are testing tifcemalimab either together with another immunotherapy drug called toripalimab or as part of a combination that also includes chemotherapy and low-dose radiotherapy. These studies are mainly looking at how safe the treatment is and whether it helps people live longer or keeps the cancer from growing for longer.

Tigulixostat

Tigulixostat, also known as LC350189, is a new drug being studied in clinical trials for the treatment of gout and hyperuricemia. These trials aim to assess the safety and effectiveness of Tigulixostat in managing serum uric acid levels, reducing gout flares, and addressing tophi in patients with gout. The studies compare Tigulixostat to placebo and existing treatments like allopurinol, exploring various dosages and treatment durations to determine its potential as a new therapeutic option for gout patients.

Related diseases and areas:

• Gout

TIL CELLS

TIL cells (tumor-infiltrating lymphocytes) are immune cells taken from a person’s tumor, grown and prepared in a lab, and then given back by infusion to help the immune system fight cancer. Several clinical trials are studying TIL-based treatments in different cancers, including advanced solid tumors, metastatic melanoma, and stage III/IV ovarian cancer. These studies mainly look at safety (side effects) and how well the treatment may control or shrink tumors.

Related diseases and areas:

• Metastatic malignant melanoma

Tildrakizumab

This article explores the use of Tildrakizumab, a monoclonal antibody that targets interleukin-23, in various clinical trials. These studies aim to evaluate its effectiveness and safety in treating conditions such as psoriasis, vitiligo, and graft-versus-host disease. The trials assess different aspects of patient outcomes, including disease severity, quality of life, and overall well-being.

Related diseases and areas:

• Chronic spontaneous urticaria
• Psoriasis
• Psoriatic arthropathy

Tilsotolimod Sodium

A new clinical trial is investigating the potential of Tilsotolimod Sodium (IMO-2125) in treating advanced melanoma. This study focuses on patients with pT3-4 cN0M0 melanoma, examining how intradermal administration of the drug might affect tumor presence in sentinel lymph nodes and impact overall patient outcomes.

Related diseases and areas:

• Malignant melanoma

Timbetasin Acetate

A new clinical trial is investigating the potential of Timbetasin Acetate, a synthetic version of a naturally occurring peptide, in treating Neurotrophic Keratopathy (NK). This eye condition, characterized by decreased corneal sensitivity and persistent epithelial defects, has been challenging to treat effectively. The study aims to evaluate the safety and efficacy of RGN-259, a 0.1% Timbetasin Acetate ophthalmic solution, compared to a placebo in patients with NK.

Related diseases and areas:

• Neurotrophic keratopathy

Timrepigene Emparvovec

This article discusses the ongoing clinical trial evaluating the long-term safety and effectiveness of Timrepigene Emparvovec, a gene therapy treatment for two rare eye conditions: Choroideremia (CHM) and X-Linked Retinitis Pigmentosa (XLRP). The study, known as SOLSTICE, follows up on patients who have previously received this innovative treatment in earlier trials, aiming to assess its lasting impact on vision and overall eye health.

Related diseases and areas:

• Choroidal dystrophy
• Retinitis pigmentosa

Tin816

A new clinical trial is underway to investigate the potential of TIN816, a drug designed to protect patients from acute kidney injury following cardiac surgery. This study aims to assess the safety, tolerability, and effectiveness of TIN816 compared to a placebo in adult patients who are at high risk for kidney complications after major heart surgery. The trial involves multiple medical centers and will provide valuable insights into how TIN816 may help preserve kidney function in vulnerable patients undergoing cardiac procedures.

Related diseases and areas:

• Acute kidney injury
• Sepsis

Tinengotinib

Tinengotinib, also known as TT-00420, is an investigational drug currently being studied in clinical trials for the treatment of various advanced solid tumors, with a particular focus on cholangiocarcinoma (bile duct cancer). These trials aim to evaluate the safety, efficacy, and potential benefits of Tinengotinib in patients who have not responded well to previous treatments. The ongoing research explores its use as a standalone therapy and in combination with other cancer treatments, offering hope for patients with limited treatment options.

Related diseases and areas:

• Cholangiocarcinoma

Tinlarebant

Tinlarebant, also known as LBS-008, is an investigational drug being studied in clinical trials for the treatment of Stargardt Disease and Geographic Atrophy. These trials aim to evaluate the safety, efficacy, and tolerability of Tinlarebant in various patient populations, including adolescents and adults. The drug is administered orally and is being tested for its potential to slow or halt the progression of these eye conditions.

Related diseases and areas:

• Dry age-related macular deg…
• Stargardt’s disease

Tinzaparin

Tinzaparin, a low molecular weight heparin (LMWH), has been the subject of several clinical trials investigating its use in various medical conditions. These trials have explored tinzaparin’s effectiveness in preventing blood clots, treating venous thromboembolism, and potentially improving outcomes in cancer patients. This article summarizes key findings from clinical trials using tinzaparin, providing insights into its applications and safety profile across different patient populations.

Related diseases and areas:

• Pulmonary embolism
• Embolism venous
• Thrombosis prophylaxis

Tioguanine

This article examines the use of Tioguanine (also known as 6-thioguanine or 6-TG) in various clinical trials for treating different types of cancer, particularly leukemia and lymphoma. Tioguanine is being studied in combination with other chemotherapy drugs to potentially improve outcomes for patients with relapsed or refractory cancers. The trials aim to determine the safety, efficacy, and optimal dosing of Tioguanine-based regimens.

Related diseases and areas:

• Non-Hodgkin’s lymphoma
• Acute lymphocytic leukaemia
• Neoplasm malignant

Tiotropium Bromide Monohydrate

This article delves into the use of Tiotropium Bromide Monohydrate in clinical trials, focusing on its potential benefits for respiratory conditions. Tiotropium Bromide Monohydrate is a long-acting bronchodilator that has been studied in various formulations and delivery devices. These trials aim to evaluate its effectiveness, absorption, and impact on patients’ quality of life, particularly in the treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Related diseases and areas:

• Hyperhidrosis
• Chronic obstructive pulmona…
• Asthma

Tipiracil

Tipiracil, often used in combination with trifluridine, is being extensively studied in clinical trials for the treatment of metastatic colorectal cancer (mCRC). This article examines various clinical trials investigating the efficacy, safety, and potential applications of tipiracil-containing regimens in different treatment settings for colorectal cancer patients.

Related diseases and areas:

• Adenocarcinoma gastric
• Oesophageal adenocarcinoma
• Colon cancer metastatic
• Metastatic gastric cancer
• Gastric cancer
• Colorectal cancer metastatic

Tipiracil Hydrochloride

Tipiracil Hydrochloride, often used in combination with other drugs, is being studied in various clinical trials for its potential in treating different types of cancer, particularly colorectal cancer. These trials aim to evaluate the drug’s effectiveness, safety, and potential benefits when combined with other treatments. The research spans different stages of cancer and explores various drug combinations to find the most effective treatment options for patients.

Related diseases and areas:

• Breast cancer
• Colorectal cancer metastatic
• Cholangiocarcinoma
• Oesophageal adenocarcinoma
• Oesophageal cancer metastatic
• Metastatic gastric cancer

Tipranavir

Tipranavir is an antiretroviral medication used in the treatment of HIV infections. This article explores various clinical trials investigating the use of Tipranavir, often in combination with Ritonavir, for HIV patients. These studies focus on aspects such as bioequivalence, pharmacokinetics, safety, tolerability, and efficacy in different patient populations, including those with limited treatment options due to drug resistance or intolerance to other antiretroviral therapies.

Tiratricol

Tiratricol, also known as Triac, is being investigated as a potential treatment for patients with monocarboxylate transporter 8 (MCT8) deficiency, also called Allan-Herndon-Dudley syndrome (AHDS). This rare genetic disorder affects thyroid hormone transport and leads to severe intellectual and motor disabilities. Clinical trials are exploring the effects of tiratricol on neurodevelopment, thyroid hormone levels, and other symptoms associated with MCT8 deficiency.

Tirbanibulin

Tirbanibulin is an emerging topical medication being studied in clinical trials for various skin conditions, primarily actinic keratosis (AK) and basal cell carcinoma (BCC). This article summarizes recent clinical trials investigating the safety, efficacy, and patient outcomes of tirbanibulin ointment for treating these common skin issues.

Related diseases and areas:

• Actinic keratosis
• Actinic cheilitis
• Basal cell carcinoma

Tirofiban Hydrochloride Monohydrate

Tirofiban Hydrochloride Monohydrate, a medication used in certain heart conditions, is currently being studied in clinical trials for its potential benefits in treating acute ischemic stroke. This article explores the ATILA project, a clinical trial investigating the use of Tirofiban compared to aspirin in patients with acute ischemic stroke caused by tandem lesions. We’ll discuss the trial’s objectives, eligibility criteria, and potential outcomes, providing valuable insights into this promising area of stroke treatment research.

Related diseases and areas:

• Angiopathy
• Ischaemic stroke

Tislelizumab

Tislelizumab is an innovative immunotherapy drug currently being studied in various clinical trials for different types of cancer. This article explores the ongoing research into Tislelizumab’s potential as a treatment option for conditions like liver cancer, lymphoma, lung cancer, and more. We’ll look at how it’s being tested alone and in combination with other therapies to potentially improve outcomes for cancer patients.

Related diseases and areas:

• Neoplasm malignant
• Gastrooesophageal cancer
• Gastric cancer
• Rectal cancer stage III
• Pseudomyxoma peritonei
• Squamous cell carcinoma of …

Tisotumab Vedotin

Tisotumab vedotin is an investigational antibody-drug conjugate being studied in clinical trials for the treatment of various solid tumors. This article summarizes key information from multiple clinical trials evaluating tisotumab vedotin’s safety, efficacy, and pharmacokinetics in patients with advanced cancers like cervical, ovarian, and lung cancer. The trials are exploring tisotumab vedotin both as a monotherapy and in combination with other cancer drugs to determine optimal dosing and identify which patients may benefit most from this targeted therapy approach.

Related diseases and areas:

• Non-small cell lung cancer …
• Pancreatic neoplasm
• Adenocarcinoma of colon
• Head and neck cancer metast…
• Head and neck cancer stage IV
• Head and neck cancer stage III

Tivozanib

Tivozanib is an investigational drug being studied in clinical trials for the treatment of various types of cancer, including renal cell carcinoma, hepatocellular carcinoma, and ovarian cancer. As a potent inhibitor of vascular endothelial growth factor receptors (VEGFRs), tivozanib works by blocking the formation of new blood vessels that tumors need to grow and spread. This article summarizes key findings from recent clinical trials evaluating the safety and efficacy of tivozanib in cancer patients.

Related diseases and areas:

• Renal cell carcinoma

Tng462

A groundbreaking clinical trial is underway to assess the safety, tolerability, and potential anti-tumor effects of TNG462, a new drug designed for patients with advanced or metastatic solid tumors that have a specific genetic deletion called MTAP. This study combines TNG462, taken orally, with an established immunotherapy drug, pembrolizumab, to explore its effectiveness in various types of cancers.

Related diseases and areas:

• Neoplasm
• Neoplasm malignant

Tobevibart

This article explores the ongoing clinical trials investigating the use of Tobevibart (VIR-3434) in treating chronic hepatitis B (HBV) and hepatitis D (HDV) infections. These studies aim to assess the safety, efficacy, and tolerability of Tobevibart, often in combination with other therapies, to potentially improve outcomes for patients with these challenging viral liver diseases.

Related diseases and areas:

• Chronic hepatitis B

Tocotrienol

Tocotrienol, a form of vitamin E, is being investigated in various clinical trials for its potential health benefits. These trials are exploring tocotrienol’s effects on conditions like cancer, liver disease, bone health, muscle strength, and neurological disorders. Researchers are studying different doses and formulations of tocotrienol to determine its safety, efficacy, and optimal use in various patient populations.

Related diseases and areas:

• Colorectal cancer metastatic

Tofacitinib Citrate

This article provides an in-depth look at the use of Tofacitinib Citrate in various clinical trials. Tofacitinib Citrate, also known by its brand name Xeljanz, is a medication that has been studied for its potential in treating a range of conditions, from autoimmune disorders to skin conditions. We’ll explore the different applications, dosage forms, and key findings from these trials to give you a comprehensive understanding of this drug’s potential in medical treatments.

Related diseases and areas:

• Colitis ulcerative
• Juvenile idiopathic arthritis

Tofersen

Tofersen, also known as BIIB067 or QALSODY, is an investigational drug being studied in clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) associated with mutations in the superoxide dismutase 1 (SOD1) gene. These trials aim to evaluate the safety, efficacy, and long-term effects of Tofersen in both symptomatic and presymptomatic individuals with SOD1-ALS.

Related diseases and areas:

• Familial amyotrophic latera…
• Amyotrophic lateral sclerosis

Toldc

Tolerogenic Dendritic Cells (TolDC), also known as “Toldc,” are being studied in clinical trials as a potential treatment for autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. These trials aim to evaluate the safety, feasibility, and potential effectiveness of TolDC therapy in managing these conditions. The research involves using the patient’s own cells to create a personalized treatment that may help regulate the immune system and reduce inflammation.

Related diseases and areas:

• Multiple sclerosis

Tolebrutinib

Tolebrutinib is an investigational drug currently being studied in clinical trials for the treatment of multiple sclerosis (MS). As a brain-penetrant Bruton’s tyrosine kinase (BTK) inhibitor, tolebrutinib shows potential in modulating inflammation and slowing disease progression in various forms of MS, including relapsing, primary progressive, and secondary progressive types. This article summarizes key information from ongoing clinical trials evaluating the safety, efficacy, and pharmacokinetics of tolebrutinib in MS patients.

Related diseases and areas:

• Secondary progressive multi…
• Progressive relapsing multi…
• Relapsing multiple sclerosis
• Primary progressive multipl…

Tolinapant Lactate

This article discusses the ongoing clinical trials investigating the use of Tolinapant Lactate, also known as ASTX660, in treating various advanced solid tumors and lymphomas. The trials aim to assess the safety, efficacy, and optimal dosing of this novel drug in patients with relapsed or refractory cancers, including peripheral T-cell lymphoma, cutaneous T-cell lymphoma, and head and neck squamous cell carcinoma.

Related diseases and areas:

• Cutaneous T-cell lymphoma
• Cervix carcinoma
• Diffuse large B-cell lymphoma
• Head and neck cancer
• Peripheral T-cell lymphoma …

Tolu Balsam

This article discusses recent clinical trials investigating the use of Tolu Balsam as part of combination therapies for different medical conditions. Tolu Balsam, a natural resin extracted from the Myroxylon balsamum tree, has been used in traditional medicine for centuries. These trials aim to explore its potential benefits when combined with other active substances in modern pharmaceutical formulations.

Related diseases and areas:

• B-cell lymphoma refractory
• B-cell lymphoma recurrent

Tolvaptan

Tolvaptan is a medication that has been the subject of numerous clinical trials to evaluate its effectiveness and safety in treating various medical conditions. This article examines the use of Tolvaptan in clinical trials for conditions such as hyponatremia, autosomal dominant polycystic kidney disease (ADPKD), cirrhosis with ascites, and heart failure. We’ll explore the drug’s mechanisms, dosing strategies, and potential benefits across different patient populations.

Related diseases and areas:

• Congenital cystic kidney di…

Tominersen

Tominersen is an investigational drug being studied for its potential in treating Huntington’s Disease, a genetic disorder that affects movement, thinking, and behavior. This article explores the ongoing clinical trial, GENERATION HD2, which aims to assess the safety, effectiveness, and biological effects of Tominersen in people with early-stage Huntington’s Disease.

Related diseases and areas:

• Huntington’s disease

Tomligisiran

A new clinical trial is exploring the potential of Tomligisiran, a novel drug, in combination with other medications for treating chronic hepatitis B (CHB). This study aims to assess the safety and effectiveness of a sequential therapy approach using Daplusiran/Tomligisiran (DAP/TOM) followed by Bepirovirsen in patients with CHB who are already on standard nucleos(t)ide analogue (NA) therapy. The trial seeks to determine the optimal dosage of DAP/TOM and evaluate its contribution to the overall treatment regimen.

Topiramate

Topiramate, an anticonvulsant medication, has been the subject of numerous clinical trials to evaluate its effectiveness and safety in treating various conditions. This article explores the use of topiramate in clinical trials for migraines, epilepsy, and other disorders, highlighting its potential benefits and side effects. We’ll examine different formulations, dosages, and compare it with other treatments to provide a comprehensive overview of topiramate’s role in modern medicine.

Related diseases and areas:

• Status epilepticus
• Petit mal epilepsy

Topotecan

Topotecan is a chemotherapy drug that has been the subject of numerous clinical trials investigating its effectiveness in treating various types of cancer and other medical conditions. This article summarizes key findings from recent clinical trials using topotecan, highlighting its potential benefits, side effects, and applications across different diseases.

Related diseases and areas:

• Breast cancer female
• Neuroendocrine carcinoma
• Ewing’s sarcoma
• Ewing’s sarcoma metastatic
• Small cell lung cancer exte…
• Extra-osseous Ewing’s sarco…

Topotecan Hydrochloride

Topotecan hydrochloride is a chemotherapy drug that has been the subject of numerous clinical trials for various types of cancer. These trials aim to evaluate its effectiveness, safety, and optimal dosing regimens in treating conditions such as ovarian cancer, cervical cancer, leukemia, and other malignancies. Researchers are exploring topotecan hydrochloride both as a single agent and in combination with other drugs to improve outcomes for patients with difficult-to-treat cancers.

Related diseases and areas:

• Medulloblastoma
• Fallopian tube cancer
• Rhabdomyosarcoma
• Rhabdoid tumour
• Ovarian cancer
• Peritoneal cancer index

TORASEMIDE

Torasemide (also known as torsemide) is a loop diuretic medication that has been studied extensively in clinical trials for various cardiovascular conditions. This potent diuretic works by inhibiting sodium and chloride reabsorption in the kidneys, increasing urine output and reducing fluid retention in the body. Clinical trials have investigated torasemide in different formulations (immediate-release and extended-release) and compared it with other diuretics like furosemide in conditions such as heart failure, hypertension, and edema. These studies have examined not only the drug’s effectiveness in managing symptoms and improving clinical outcomes but also its pharmacokinetic properties and safety profile across diverse patient populations. Understanding the evidence from these clinical trials helps patients and healthcare providers make informed decisions about using torasemide as part of treatment plans for cardiovascular and renal conditions.

Related diseases and areas:

• Hypertension

Toripalimab

Toripalimab, a promising immunotherapy drug, is currently being studied in various clinical trials for its effectiveness in treating different types of cancer. These trials aim to evaluate how Toripalimab, either alone or in combination with other treatments, can improve outcomes for patients with conditions such as lung cancer, head and neck cancers, and cervical cancer. This article summarizes key information about ongoing Toripalimab clinical trials and their potential impact on cancer treatment.

Related diseases and areas:

• Hepatocellular carcinoma
• Nasopharyngeal cancer recur…

Tovinontrine

Tovinontrine, also known as CRD-750, is an investigational drug currently being studied in clinical trials for its potential to treat different types of heart failure. These trials aim to evaluate the safety and effectiveness of Tovinontrine in patients with chronic heart failure, both with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF). The studies focus on how Tovinontrine affects important biomarkers related to heart function and overall patient well-being.

Tovorafenib

Tovorafenib, also known as DAY101, is an oral type II RAF kinase inhibitor being investigated in several clinical trials for the treatment of pediatric low-grade gliomas and other solid tumors with alterations in the MAPK pathway. This article summarizes key information about ongoing clinical trials evaluating tovorafenib’s safety and efficacy in various patient populations.

Related diseases and areas:

• Craniopharyngioma
• Malignant glioma